Men's Perspectives on Selecting Their Prostate Cancer Treatment

被引:68
|
作者
Xu, Jinping [1 ]
Dailey, Rhonda K. [1 ]
Eggly, Susan [2 ]
Neale, Anne Victoria [1 ]
Schwartz, Kendra L. [1 ]
机构
[1] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Karmanos Canc Inst, Detroit, MI 48202 USA
[2] Wayne State Univ, Dept Oncol, Karmanos Canc Inst, Detroit, MI 48202 USA
关键词
prostate cancer; treatment; racial disparities; DECISION-MAKING; TRENDS; MANAGEMENT; CARCINOMA;
D O I
10.1016/S0027-9684(15)30359-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In the context of scientific uncertainty, treatment choices for localized prostate cancer vary, but reasons for this variation are unclear. We explored how black and white American men made their treatment decision. Methods: Guided by conceptual model, we conducted semi-structured interviews of 21 American (14 black and 7 white) men with recently diagnosed localized prostate cancer. Results: Physician recommendation was very important in the treatment decision, but patient self-perception/values and attitudes/beliefs about prostate cancer were also influential. Patients who chose surgery believed it offered the best chance of cure and were more concerned that the cancer might spread if not surgically removed. Patients who chose radiation therapy believed it offered equal efficacy of cure but fewer side effects than surgery. Fear of future consequences was the most common reason to reject watchful waiting. Anecdotal experiences of family and friends were also important, especially in deciding "what not to do." The new technology of robotic-assisted prostatectomy provided optimism for men who wanted surgery but feared morbidity. associated with traditional open surgery. Few men seemed aware that treatment did not guarantee improved survival. Conclusion: Most men reported making "the best choice for me" by taking into account medical information and personal factors. Perceptions of treatment efficacy and side effects, which derived mainly from physicians' descriptions and/or anecdotal experiences of family and friends, were the most influential factors in men's treatment decision. By understanding factors that influence patients' treatment decisions, clinicians may be more sensitive to individual patients' preferences/concerns and provide more patient-centered care.
引用
收藏
页码:468 / 478
页数:11
相关论文
共 50 条
  • [31] Impact of Health Information-Seeking Behavior and Personal Factors on Preferred Role in Treatment Decision Making in Men With Newly Diagnosed Prostate Cancer
    Davison, Joyce
    Breckon, Erin Nicole
    CANCER NURSING, 2012, 35 (06) : 411 - 418
  • [32] Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer
    Jaclyn LF Bosco
    Barbara Halpenny
    Donna L Berry
    Health and Quality of Life Outcomes, 10
  • [33] A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic
    Hurwitz, Lauren M.
    Cullen, Jennifer
    Elsamanoudi, Sally
    Kim, Daniel J.
    Hudak, Jane
    Colston, Maryellen
    Travis, Judith
    Kuo, Huai-Ching
    Porter, Christopher R.
    Rosner, Inger L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (05) : 233.e17 - 233.e25
  • [34] Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance
    Brady, Lauren
    Newcomb, Lisa F.
    Zhu, Kehao
    Zheng, Yingye
    Boyer, Hilary
    De Sarkar, Navonil
    McKenney, Jesse K.
    Brooks, James D.
    Carroll, Peter R.
    Dash, Atreya
    Ellis, William J.
    Filson, Christopher P.
    Gleave, Martin E.
    Liss, Michael A.
    Martin, Frances
    Morgan, Todd M.
    Thompson, Ian M.
    Wagner, Andrew A.
    Pritchard, Colin C.
    Lin, Daniel W.
    Nelson, Peter S.
    CANCER MEDICINE, 2022, 11 (22): : 4332 - 4340
  • [35] Influence of sociodemographic factors on treatment's choice for localized prostate cancer in Portugal
    Pereira-Lourenco, Mario
    Vieira e Brito, Duarte
    Peralta, Joao Pedro
    Godinho, Ricardo
    Conceicao, Paulo
    Reis, Mario
    Rabaca, Carlos
    Sismeiro, Amilcar
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (01) : 45 - 49
  • [36] Multiple physician recommendations for prostate cancer treatment: a Pandora's box for patients?
    Underwood, Willie, III
    Orom, Heather
    Poch, Michael
    West, Brady T.
    Lantz, Paula M.
    Chang, Sam S.
    Fowke, Jay H.
    CANADIAN JOURNAL OF UROLOGY, 2010, 17 (05) : 5346 - 5354
  • [37] Treatment-related osteoporosis in men with prostate cancer
    Kazanis M.
    Smith M.R.
    Clinical Reviews in Bone and Mineral Metabolism, 2004, 2 (2): : 115 - 122
  • [38] Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer
    Chamie, Karim
    Daskivich, Timothy J.
    Kwan, Lorna
    Labo, Jessica
    Dash, Atreya
    Greenfield, Sheldon
    Litwin, Mark S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (05) : 492 - 499
  • [39] Androgen replacement in men undergoing treatment for prostate cancer
    Rhoden, Ernani Luis
    Averbeck, Marcio Augusto
    Teloken, Patrick E.
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (09) : 2202 - 2208
  • [40] Men, Food, and Prostate Cancer: Gender Influences on Men's Diets
    Mroz, Lawrence W.
    Chapman, Gwen E.
    Oliffe, John L.
    Bottorff, Joan L.
    AMERICAN JOURNAL OF MENS HEALTH, 2011, 5 (02) : 177 - 187